A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 84,796 shares of DVAX stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
84,796
Previous 82,590 2.67%
Holding current value
$1.09 Million
Previous $920,000 17.61%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$10.28 - $13.66 $22,677 - $30,133
2,206 Added 2.67%
84,796 $1.08 Million
Q3 2024

Nov 14, 2024

BUY
$10.05 - $11.61 $58,038 - $67,047
5,775 Added 7.52%
82,590 $920,000
Q2 2024

Aug 14, 2024

BUY
$10.73 - $12.58 $824,224 - $966,332
76,815 New
76,815 $862,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.62B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.